Analysts at Goldman Sachs have picked multiple stocks set to “rapidly outgrow” their pre-Covid earnings as the post-pandemic reopening picks up in Europe.
The bank said all of the large global companies on its “Reopening Beneficiaries” list have more than 10% potential upside to their 12-month share price targets — and all are buy-rated by its analysts.
